42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures

Key Takeaways Explain This Topic AI

Proximal 5th metatarsal fractures are divided into three distinct anatomical zones with vastly different vascular supplies: Zone 1 (pseudo-Jones tuberosity avulsion; >90% of cases; managed with hard-soled shoe and full weight-bearing as tolerated), Zone 2 (true Jones fracture at the metaphyseal-diaphyseal junction within 1.5 cm of the tuberosity; vascular watershed zone requiring strict non-weight-bearing cast for 6-8 weeks or percutaneous screw fixation), and Zone 3 (diaphyseal stress fracture).

Lisfranc joint injuries (tarsometatarsal fracture-dislocations) are characterized by the pathognomonic physical finding of plantar midfoot ecchymosis; bilateral weight-bearing plain radiographs demonstrating >2 mm diastasis between the 1st and 2nd metatarsal bases or an avulsion 'fleck sign' mandate urgent orthopedic consultation for surgical reduction and internal fixation.

Midshaft clavicle fractures (Allman Group I, 80% of clavicle fractures) are successfully treated conservatively with a simple sling for 4 to 6 weeks; clear indications for operative open reduction and internal fixation (ORIF) include open fracture, neurovascular compromise, severe skin tenting, >100% displacement, or shortening >2 cm.

In any patient presenting with severe ankle trauma—particularly those with medial clear space widening, deltoid ligament tenderness, or medial malleolar fracture—palpation of the proximal fibula is mandatory to avoid missing a Maisonneuve fracture, which involves syndesmotic disruption and requires operative syndesmotic stabilization.

Non-displaced lesser toe fractures are managed conservatively with buddy taping to the adjacent toe and a rigid-soled shoe for 3 to 4 weeks, whereas great toe (hallux) fractures require orthopedic evaluation if displaced >2 mm, intra-articular, or involving >25% of the first metatarsophalangeal articular surface.

Last updated: September 2026

Proximal 5th Metatarsal Fractures: Anatomical Zones & Vascular Watersheds

Fractures of the fifth metatarsal represent the most common metatarsal fractures encountered in primary care and sports medicine clinics, accounting for over 60% of all foot fractures. Clinical management and healing prognosis are entirely governed by the Lawrence and Botte classification , which divides the proximal fifth metatarsal into three distinct anatomical zones based on vascular perfusion patterns. PROXIMAL 5TH METATARSAL ANATOMICAL ZONES

• ┌──────────────────────────────────────────────────┐
• │ ZONE 1: Pseudo-Jones (Tuberosity Avulsion) │
• │ • >90% of proximal 5th metatarsal fractures │
• │ • Extra-articular or into cuboid joint │
• │ • Rich cancellous blood supply ──► HEALS RAPID │
• ├──────────────────────────────────────────────────┤
• │ ZONE 2: True Jones Fracture │
• │ • Metaphyseal-diaphyseal junction (1.5 cm) │
• │ • Enters 4th-5th intermetatarsal articulation │
• │ • VASCULAR WATERSHED ──► High Nonunion (15-30%)│
• ├──────────────────────────────────────────────────┤
• │ ZONE 3: Diaphyseal Stress Fracture │
• │ • Distal to 4th-5th intermetatarsal joint │
• │ • Overuse in athletes / runners │
• │ • Prodromal pain, cortical sclerosis │
• └──────────────────────────────────────────────────┘
• 1. Zone 1: Pseudo-Jones Fracture (Tuberosity Avulsion)

Anatomy & Mechanism : Represents >90% of proximal 5th metatarsal fractures. Occurs when the foot is subjected to sudden, forceful inversion while plantarflexed. Historically attributed to avulsion by the peroneus brevis tendon, anatomical and biomechanical studies have conclusively demonstrated that the vast majority of these avulsions are driven by the lateral cord of the plantar aponeurosis .

Vascularity & Prognosis : The metatarsal tuberosity features an exceptionally rich cancellous blood supply derived from metaphyseal perforators. As a result, nonunion is exceedingly rare (<1%).

Treatment Protocol :

Fully conservative management.

Symptomatic weight-bearing as tolerated in a rigid-soled post-operative shoe or a short pneumatic walking boot.

Transition to supportive athletic sneakers as pain diminishes over 3 to 6 weeks.

Non-weight-bearing casting is strictly unnecessary and produces avoidable calf atrophy, joint stiffness, and deep vein thrombosis (DVT) risk.

2. Zone 2: True Jones Fracture

Anatomy & Definition : First described by Sir Robert Jones in 1902. A transverse fracture occurring at the metaphyseal-diaphyseal junction , precisely within 1.5 cm distal to the tuberosity . Crucially, the fracture line extends into the 4th-5th intermetatarsal articulation , NOT the cuboid-metatarsal joint.

Mechanism : Sudden, forceful adduction or inversion load applied to the forefoot while the heel is elevated (e.g., pivoting or cutting maneuvers in basketball, soccer, or dance).

The Vascular Watershed Trap : The metaphyseal-diaphyseal junction represents a critical vascular watershed. The endosteal nutrient artery enters the middle third of the diaphyseal cortex and arborizes proximally, terminating prior to reaching the metaphyseal-diaphyseal border. Consequently, Zone 2 fractures suffer from severe relative ischemia, resulting in delayed union in 30% to 50% and primary nonunion in 15% to 25% of cases if managed with early weight-bearing.

Management Guidelines :

Sedentary / Low-Demand Patients : Strict non-weight-bearing short-leg cast for 6 to 8 weeks , verified by serial radiographic evidence of progressive bridging callus prior to weight advancement.

Competitive Athletes & Active Manual Laborers : Early orthopedic referral for percutaneous intramedullary cannulated screw fixation . Operative stabilization achieves union rates >95%, slashes time to union in half, and permits safe return to competitive athletics within 6 to 8 weeks, compared to high refracture rates associated with prolonged casting.

3. Zone 3: Proximal Diaphyseal Stress Fracture

Anatomy & Mechanism : Located in the proximal diaphysis distal to the 4th-5th intermetatarsal junction. These represent true chronic overuse stress fractures resulting from repetitive cyclical mechanical overload in long-distance runners, military recruits, and basketball players.

Radiographic Features : Often demonstrate a history of chronic prodromal lateral foot pain. Radiographs reveal focal periosteal reaction, external cortical thickening, or medullary canal sclerosis narrowing the marrow cavity adjacent to a radiolucent fracture line (Torg classification Type II or III).

Management : Zone 3 stress fractures carry the highest rate of nonunion among all foot fractures. Management requires prolonged non-weight-bearing cast immobilization (12 to 20 weeks) or, much more commonly, surgical intramedullary screw fixation with or without open autologous bone grafting.

Proximal 5th Metatarsal Fracture Classification & Management Comparison

Zone Fracture Type Anatomical Landmark Blood Supply Primary Management Nonunion Risk

Zone 1 Pseudo-Jones / Avulsion Tuberosity / apophysis; enters cuboid joint Abundant metaphyseal cancellous flow Hard-soled shoe or walking boot; weight-bearing as tolerated <1% (exceptional)

Zone 2 True Jones Fracture Metaphyseal-diaphyseal junction (1.5 cm); enters 4th-5th joint Vascular watershed; poor retrograde perfusion Strict non-weight-bearing cast for 6-8 weeks (sedentary) OR Screw fixation (athletes) 15% to 25%

Zone 3 Diaphyseal Stress Fracture Proximal diaphysis distal to intermetatarsal joint Poor endosteal perfusion; chronic microdamage Prolonged non-weight-bearing cast (12-20 wk) OR intramedullary screw fixation 30% to 50%

Lisfranc Joint Injury (Tarsometatarsal Complex)

The Lisfranc joint complex comprises the articulations between the midfoot (the three cuneiforms and cuboid) and the forefoot (bases of the five metatarsals). The second metatarsal base is deeply recessed proximally between the medial and lateral cuneiforms, forming an osseous "keystone" mortise that provides intrinsic transverse stability.

The Lisfranc Ligament

The Lisfranc ligament is a massive, oblique intra-articular ligament running from the plantar-lateral surface of the medial cuneiform to the plantar-medial base of the second metatarsal . Crucially, while strong transverse ligaments interconnect the bases of the 2nd through 5th metatarsals, there is NO transverse ligament connecting the 1st and 2nd metatarsal bases . Stability of the entire medial midfoot column depends entirely on the integrity of the Lisfranc ligament.

Mechanism of Injury & Clinical Presentation

Mechanisms : High-energy motor vehicle collisions (foot slammed against floorboard/brake) or low-energy athletic axial loading (an athlete falling forward over an opponent with the foot held in extreme hyperplantarflexion , causing the 2nd metatarsal base to rupture dorsally out of its keystone socket).

Clinical Presentation : Severe midfoot pain, gross dorsal midfoot edema, inability to bear weight on the heel or toes, and exquisite point tenderness along the tarsometatarsal line.

PATHOGNOMONIC PHYSICAL SIGN : Plantar midfoot ecchymosis ("Lisfranc sign") . Blood extravasates through the ruptured inferior plantar capsule into the deep plantar vault. Clinical axiom: In acute foot trauma, plantar ecchymosis is pathognomonic for a Lisfranc injury until proven otherwise!

Provocative Examination : The Midfoot Stress Test : Grasp the hindfoot (calcaneus) firmly with one hand while using the other hand to passively pronate and abduct the forefoot. Severe midfoot pain or palpable instability confirms ligamentous disruption.

Radiographic Diagnostic Criteria

• Important
• THE CRITICAL LISFRANC IMAGING PROTOCOL

Standard non-weight-bearing foot radiographs miss up to 20% to 50% of subtle ligamentous Lisfranc disruptions !

When clinical suspicion is present, Bilateral Weight-Bearing Plain Radiographs (AP, lateral, and 30° oblique) are mandatory.

Four Cardinal Radiographic Signs of Lisfranc Disruption :

Widening >2 mm between the 1st and 2nd metatarsal bases on the weight-bearing AP view.

Loss of Colinear Alignment : On the AP view, the medial border of the 2nd metatarsal base must align continuously with the medial border of the intermediate cuneiform. Lateral step-off >1 mm indicates subluxation.

Oblique View Step-off : The medial border of the 4th metatarsal base must align precisely with the medial border of the cuboid.

The "Fleck Sign" : A pathognomonic small avulsion bone fragment visible within the 1st-2nd intermetatarsal space, reflecting bony avulsion of the Lisfranc ligament attachment. LISFRANC JOINT RADIOGRAPHIC ALIGNMENT

• Normal AP Alignment Lisfranc Disruption (>2 mm Diastasis)
• ───────────────────────────── ──────────────────────────────────────
• [Medial] [Middle] [Medial] [Middle]
• Cuneiform Cuneiform Cuneiform Cuneiform
• │ │ │ │
• │ │ │ ►► GAP ◄◄ │
• ▼ ▼ ▼ [>2 mm Fleck] ▼
• [1st MT] [2nd MT] [1st MT] [2nd MT]
• (Colinear medial borders) (Lateral displacement / subluxation)
• Management Guidelines

True Non-Displaced (<2 mm diastasis on weight-bearing views) : Strict non-weight-bearing short-leg cast for 6 weeks, followed by repeat weight-bearing radiographs. If alignment remains pristine, transition to a walking boot with custom rigid orthotic arch support.

Displaced (>2 mm diastasis or any articular step-off) : Urgent orthopedic surgical referral for operative reduction and internal fixation (ORIF) using trans-articular cortical screws or primary arthrodesis. Missed or improperly managed Lisfranc injuries lead to progressive longitudinal arch collapse (post-traumatic flatfoot), chronic neuropathic pain, and severe, irreversible midfoot degenerative osteoarthritis.

Clavicle Fractures & Allman Classification

Clavicle fractures account for 2% to 5% of all adult fractures and up to 10% to 15% of all pediatric fractures, resulting from direct impacts to the lateral shoulder during athletic collisions, falls from bicycles, or motor vehicle crashes.

Allman Classification System

Group I: Middle Third / Midshaft (80% of clavicle fractures) :

Occurs at the transition between the middle and lateral thirds, where the cross-sectional diameter is thinnest and lacks stabilizing muscular or ligamentous attachments.

The sternocleidomastoid muscle displaces the proximal medial fragment superiorly and posteriorly, while the weight of the arm and pectoralis major pull the distal lateral fragment inferiorly and medially.

Group II: Distal / Lateral Third (15% of clavicle fractures) :

Subclassified by Neer based on the relationship to the coracoclavicular (CC) ligaments (conoid and trapezoid):

Type I : CC ligaments intact; minimally displaced; stable.

Type II : CC ligaments detached from the medial fragment (Type IIA: conoid and trapezoid intact but medial to fracture; Type IIB: conoid torn, trapezoid intact). Significant superior displacement of the medial fragment; high nonunion rate (up to 30%); frequently requires surgical reconstruction.

Type III : Intra-articular fracture entering the acromioclavicular (AC) joint; managed conservatively unless symptomatic AC arthritis develops.

Group III: Proximal / Medial Third (5% of clavicle fractures) :

High-energy trauma. Requires meticulous physical and CT evaluation to exclude posterior sternoclavicular dislocation and catastrophic mediastinal vascular injury (subclavian vessels, carotid artery, internal jugular vein) or pneumothorax.

Management: Non-Operative vs. Surgical ORIF MIDSHAFT CLAVICLE MANAGEMENT PROTOCOL

• [Midshaft Clavicle Fracture Confirmed on Upright AP / 15° Cephalic Views]
• │
• ┌──────────────────┴──────────────────┐
• ▼ ▼
• [SURGICAL ORIF INDICATIONS] [CONSERVATIVE MANAGEMENT CANDIDATE]
• Open fracture • Non-displaced or minimally displaced
• Neurovascular compromise • Cortical contact maintained
• Severe skin tenting / blanching • Shortening <2 cm (males) / <1.5 cm (females)
• 100% displacement (no contact) │
• Shortening >2 cm ▼
• "Floating shoulder" (scapula neck) [SIMPLE SLING FOR 4-6 WEEKS]
• │ • Simple sling = Figure-of-8 (less skin breakdown)
• ▼ • Gentle pendulum exercises at 2-3 weeks
• [ORTHOPEDIC SURGICAL REFERRAL] • Progressive active rehab at 4-6 weeks
• Precontoured superior plate ORIF • Contact sports restricted until 8-12 weeks

Non-Operative Protocol : First-line standard of care for non-displaced or minimally displaced midshaft fractures. Randomized trials have conclusively proven that a simple sling provides equivalent clinical union rates, fewer cosmetic/skin complications, and substantially higher patient satisfaction compared to uncomfortable figure-of-eight braces .

Indications for Surgical ORIF (Superior or Anterior-Inferior Plating) :

Absolute : Open fractures; acute neurovascular compromise (brachial plexus deficit or diminished distal pulses); severe skin tenting threatening impending ischemic necrosis; "floating shoulder" (ipsilateral clavicle fracture and scapular neck fracture).

Relative : Complete displacement with 100% loss of cortical contact ; fracture shortening >2 cm in males or >1.5 cm in females (shortening alters scapulothoracic kinematics, decreasing shoulder abduction endurance by up to 20%); symptomatic nonunion after 3 to 6 months.

Proximal Fibula Fractures & The Maisonneuve Injury

A Maisonneuve fracture is an unstable pronation-external rotation injury of the lower extremity comprising a rupture of the medial ankle stabilizers associated with a high fracture of the proximal fibula. MAISONNEUVE INJURY KINEMATICS

• 1. Violent External Rotation Force at Ankle
• │
• ▼
• 2. Medial Failure: Deltoid Ligament Tear
• OR Medial Malleolus Avulsion Fracture
• │
• ▼
• 3. Syndesmotic Disruption: AITFL & PITFL Tear;
• Interosseous Membrane Tears Proximalward
• │
• ▼

4. Kinetic Energy Exits Proximally:

SPIRAL FRACTURE OF PROXIMAL FIBULAR NECK!

Caution

THE GOLDEN RULE OF ANKLE TRAUMA: PALPATE THE PROXIMAL FIBULA!

The Diagnostic Hazard : Patients with a Maisonneuve fracture present complaining exclusively of severe medial ankle pain and swelling. Because the proximal fibular fracture is remote from the ankle and often painless at rest, clinicians who fail to examine the entire leg will misdiagnose this catastrophic injury as an "isolated deltoid ligament sprain" or "isolated medial malleolus fracture"!

Mandatory Physical Examination : In EVERY patient presenting with an ankle injury—especially those with medial clear space widening, medial tenderness, or syndesmotic pain—the clinician must palpate the proximal fibular head and neck along its entire length .

Radiographic Protocol : If proximal fibular tenderness is elicited, or if ankle mortise views demonstrate medial clear space widening >4 mm or tibiofibular clear space >6 mm , order Full-Length Anteroposterior and Lateral Tibia-Fibula Radiographs .

Definitive Treatment : The Maisonneuve fracture represents a complete disruption of the distal tibiofibular syndesmosis. Closed casting is strictly contraindicated due to high failure rates. Treatment is urgent orthopedic referral for surgical syndesmotic fixation using syndesmotic screws or dynamic suture-button constructs (TightRope).

Phalanx (Toe) Fractures: Lesser Toes vs. Great Toe

Toe fractures are ubiquitous in ambulatory primary care, typically resulting from direct axial impact ("stubbing" a bare toe against furniture) or crush trauma from dropped heavy objects.

Lesser Toe Fractures (Digits 2 through 5)

Diagnostic Approach : Obtain 3-view plain radiographs (AP, lateral, oblique) to assess displacement, intra-articular extension, and rotational deformity.

Management Protocol :

Non-displaced or minimally displaced lesser toe fractures are managed conservatively with buddy taping to the adjacent uninjured toe for 3 to 4 weeks.

Technique : Place a small piece of gauze or cotton in the interdigital web space between the toes prior to applying tape to prevent moisture accumulation, maceration, and skin breakdown.

Provide a stiff-soled post-operative shoe to prevent painful metatarsophalangeal extension during walking.

Grossly displaced or angulated fractures: Perform a digital nerve block (1% to 2% plain lidocaine), apply gentle manual axial traction to reduce the deformity, and buddy tape.

Great Toe (Hallux) Fractures

Biomechanical Significance : The hallux bears over 50% of total body weight during the terminal push-off phase of the normal gait cycle. Malunion of the great toe causes severe gait alterations, metatarsalgia, and debilitating post-traumatic arthritis.

Orthopedic Surgical Referral Indications :

Intra-articular fracture involving >25% of the first metatarsophalangeal (MTP) or interphalangeal (IP) articular surface.

Fracture displacement >2 mm after closed reduction attempt.

Irreducible fracture or significant rotational malalignment.

Open fractures or comminuted intra-articular sesamoid fractures.

Conservative Protocol : Truly non-displaced extra-articular hallux fractures are immobilized in a short-leg walking boot with a rigid toe plate extension (or toe spica) for 4 to 6 weeks, with heel-weight-bearing initially.

Loading diagram... Proximal 5th Metatarsal & Lisfranc Diagnostic Decision Tree